IRS2 and Insulin resistance: Lipid intermediates, such as diacylglycerols, could inhibit insulin signaling pathways by impairing insulin receptor substrate 2 (IRS2) phosphorylation as well as elevating the PKC pathway in the liver resulting in insulin resistance (15).